NASDAQ:VIVE - Viveve Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Viveve Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.44 -0.36 (-20.00 %) (As of 02/21/2020 04:48 AM ET) Add Compare Today's Range$1.37Now: $1.44▼$1.6450-Day Range$0.91MA: $1.07▼$1.8052-Week Range$0.79Now: $1.44▼$110.50Volume6.31 million shsAverage Volume2.80 million shsMarket Capitalization$2.13 millionP/E RatioN/ADividend YieldN/ABeta0.31 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components. It markets its products through sales employees and distributors in the United States, the Asia Pacific, Europe, the Middle East, Latin America, and Canada. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:VIVE Previous SymbolOTCMKTS:PLCSD CUSIPN/A CIK879682 Webhttp://www.viveve.com/ Phone720-696-8100Debt Debt-to-Equity RatioN/A Current Ratio3.05 Quick Ratio2.39Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$18.52 million Price / Sales0.11 Cash FlowN/A Price / Cash FlowN/A Book Value$10.60 per share Price / Book0.14Profitability EPS (Most Recent Fiscal Year)($161.00) Net Income$-49,320,000.00 Net Margins-429.71% Return on EquityN/A Return on Assets-123.23%Miscellaneous Employees67 Outstanding Shares1,477,000Market Cap$2.13 million Next Earnings Date3/12/2020 (Estimated) OptionableOptionable Receive VIVE News and Ratings via Email Sign-up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:VIVE Rates by TradingView Viveve Medical (NASDAQ:VIVE) Frequently Asked Questions What is Viveve Medical's stock symbol? Viveve Medical trades on the NASDAQ under the ticker symbol "VIVE." How were Viveve Medical's earnings last quarter? Viveve Medical Inc (NASDAQ:VIVE) released its earnings results on Thursday, November, 7th. The company reported ($13.51) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($16.00) by $2.49. The business earned $1.05 million during the quarter. View Viveve Medical's Earnings History. When is Viveve Medical's next earnings date? Viveve Medical is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Viveve Medical. What price target have analysts set for VIVE? 5 brokers have issued 1 year price objectives for Viveve Medical's shares. Their forecasts range from $0.20 to $1.00. On average, they expect Viveve Medical's stock price to reach $0.60 in the next year. This suggests that the stock has a possible downside of 58.3%. View Analyst Price Targets for Viveve Medical. What is the consensus analysts' recommendation for Viveve Medical? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viveve Medical in the last year. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Viveve Medical. What are Wall Street analysts saying about Viveve Medical stock? Here are some recent quotes from research analysts about Viveve Medical stock: 1. Maxim Group analysts commented, "Yesterday, after the Market close, VIVE reported 2Q19 revenue inline with our estimates adjusted for the preannouncement on July 22, 2019, but lower than consensus." (8/9/2019) 2. Mizuho analysts commented, "We expect these data readouts and milestone events will be the key drivers of VIVE shares in 2019/2020." (3/15/2019) Has Viveve Medical been receiving favorable news coverage? Media coverage about VIVE stock has trended somewhat positive this week, according to InfoTrie. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Viveve Medical earned a daily sentiment score of 1.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for Viveve Medical. Are investors shorting Viveve Medical? Viveve Medical saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 184,000 shares, an increase of 12.0% from the January 15th total of 164,300 shares. Based on an average trading volume of 1,409,700 shares, the days-to-cover ratio is currently 0.1 days. Approximately 4.6% of the shares of the stock are short sold. View Viveve Medical's Current Options Chain. Who are some of Viveve Medical's key competitors? Some companies that are related to Viveve Medical include Digirad (DRAD), Vaso (VASO), Non-Invasive Monitoring Systems (NIMU), Reshape Lifesciences (RSLS), ReShape Lifesciences (RSLSD), CHF Solutions (CHFS), Nexeon Medsystems (NXNN), Escalon Medical (ESMC), Trimedyne (TMED), Guided Therapeutics (GTHP), Magna-Lab (MAGAA), Echo Therapeutics (ECTE), Newcardio (NWCI), 21st North (ULGX) and IMRIS (IMRSQ). What other stocks do shareholders of Viveve Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), Fortive (FTV), HP (HPQ), Lowe's Companies (LOW), Western Digital (WDC), SCYNEXIS (SCYX), Viking Therapeutics (VKTX), Trevena (TRVN) and AVEO Pharmaceuticals (AVEO). Who are Viveve Medical's key executives? Viveve Medical's management team includes the folowing people: Mr. Scott C. Durbin, CEO & Director (Age 50)Mr. James Gregory Atkinson, Chief Bus. Officer & Pres (Age 61)Mr. Jim B. Robbins, VP of Fin. & Admin., Principal Accounting Officer and Principal Financial Officer (Age 55)Ms. Deborah A. Jorn, Sr. Advisor to the CEO & Director (Age 61)Mr. Martin Kerber, VP of Operations When did Viveve Medical IPO? (VIVE) raised $13 million in an initial public offering (IPO) on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager. How do I buy shares of Viveve Medical? Shares of VIVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Viveve Medical's stock price today? One share of VIVE stock can currently be purchased for approximately $1.44. How big of a company is Viveve Medical? Viveve Medical has a market capitalization of $2.13 million and generates $18.52 million in revenue each year. The company earns $-49,320,000.00 in net income (profit) each year or ($161.00) on an earnings per share basis. Viveve Medical employs 67 workers across the globe.View Additional Information About Viveve Medical. What is Viveve Medical's official website? The official website for Viveve Medical is http://www.viveve.com/. How can I contact Viveve Medical? Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The company can be reached via phone at 720-696-8100 or via email at [email protected] MarketBeat Community Rating for Viveve Medical (NASDAQ VIVE)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 279 (Vote Outperform)Underperform Votes: 188 (Vote Underperform)Total Votes: 467MarketBeat's community ratings are surveys of what our community members think about Viveve Medical and other stocks. Vote "Outperform" if you believe VIVE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VIVE will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/21/2020 by MarketBeat.com StaffFeatured Article: What is the market perform rating?
